Craft

Senseonics

Stock Price

$0.3

2024-10-29

Market Capitalization

$203.2 M

2024-10-29

Revenue

$35.3 M

FY, 2025

Senseonics Summary

Company Summary

Overview
Senseonics Holdings is a medical technology company focused on the development and commercialization of glucose monitoring products. Its Eversense and Eversense XL CGM systems are designed to continually measure glucose levels in people with diabetes via an under-the-skin sensor, a smart transmitter, and an app for real-time diabetes monitoring and management.
Type
Public
Status
Active
Founded
1996
HQ
Germantown, MD, US | view all locations
Website
http://senseonics.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Mukul Jain

    Mukul Jain, Chief Operating Officer

  • Rick Sullivan

    Rick Sullivan, Chief Financial Officer

    • Abhi Chavan

      Abhi Chavan, Vice President, Engineering, R&D

    • Katherine Tweden

      Katherine Tweden, Vice President, Clinical Sciences

    Operating MetricsView all

    Trademarks (Foreign)

    116
    12.6%

    FY, 2020

    Trademark Applications (Foreign)

    20
    23.1%

    FY, 2020

    Patent Applications

    185
    14.4%

    FY, 2020

    LocationsView all

    1 location detected

    • Germantown, MD HQ

      United States

      20451 Seneca Meadows Pkwy

    Senseonics Financials

    Summary Financials

    Revenue (Q1, 2026)
    $11.7M
    Gross profit (Q1, 2026)
    $6.9M
    Net income (Q1, 2026)
    ($32.3M)
    Cash (Q1, 2026)
    $29.6M
    EBIT (Q1, 2026)
    ($31.8M)
    Enterprise value
    $216.7M

    Footer menu